Purpose: To determine the 24-h effects of brinzolamide/brimonidine tartrate 1%/0.2% fixed
combination (BBFC) on intraocular pressure (IOP), ocular perfusion pressure (OPP), blood …

Purpose To determine the intraocular pressure (IOP)-lowering effect of fixed-combination
brinzolamide 1%/brimonidine 0.2%(BBFC) over a 24-hour period. Design Prospective …

Objective: To compare brimonidine/timolol fixed combination (BrTFC; Combigan with
dorzolamide/timolol fixed combination (DTFC; Cosopt in terms of ability to lower intraocular …

Purpose: This study compared the intraocular pressure (IOP)-lowering efficacy of fixed-
combination brinzolamide 1%/brimonidine 0.2%(BBFC) with that of its component …

Purpose: To evaluate the efficacy of fixed combination brimonidine-timolol (FCBT) versus
fixed combination dorzolamide-timolol (FCDT) given twice daily in patients with primary …

Objective To demonstrate that the intraocular pressure (IOP)-lowering efficacy of a twice-
daily brinzolamide 10 mg/mL (BRINZ)/brimonidine 2 mg/mL (BRIM) fixed-dose combination …

Purpose To evaluate the additive ocular hypotensive effect of the combination of
brimonidine and timolol on intraocular pressure (IOP) reduction in patients with glaucoma …

Purpose To determine whether intraocular pressure (IOP) lowering with fixed-combination
brinzolamide/brimonidine (BBFC) adjunctive to a prostaglandin analog (PGA) was superior …

PURPOSE: To compare the safety and intraocular pressure (IOP)-lowering efficacy of
brinzolamide 1%/timolol 0.5% fixed combination with brinzolamide 1% or timolol 0.5% alone …

Purpose To evaluate the 24-h intraocular pressure (IOP) control of brimonidine/timolol fixed
combination (BTFC) versusthe unfixed combination of its individual components, each …